Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era. - Wikidata - awgldk - TriplyDB

Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.

Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.

http://www.wikidata.org/entity/Q34806379

about

Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection Spontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature Review Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methods HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.Circulating serum free light chains as predictive markers of AIDS-related lymphoma.The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment.Biomarkers of HIV-associated Cancer.Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution Cancer biomarkers in HIV patients A challenge for the future: aging and HIV infection.Acceleration of age-associated methylation patterns in HIV-1-infected adults.Meeting the challenge of hematologic malignancies in sub-Saharan Africa Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection.Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010 Immune reconstitution inflammatory syndrome-associated Burkitt lymphoma after combination antiretroviral therapy in HIV-infected patients.Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047 Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies.Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.High cancer-related mortality in an urban, predominantly African-American, HIV-infected population Liver space occupying lesion in a patient with secondary immunodeficiency.A review of the role of lymphoma markers and occupational and environmental exposures.AIDS-Associated Cardiac Lymphoma-A Review: Apropos a Case Report.The silent war of CMV in aging and HIV infection The Effect of Antiretroviral Combination Treatment on Epstein-Barr Virus (EBV) Genome Load in HIV-Infected Patients.The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases.The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia.Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.Patterns of HIV viremia and viral suppression before diagnosis of non-AIDS-defining cancers in HIV-infected individuals.CD4-Positive T-Cell Primary Central Nervous System Lymphoma in an HIV Positive Patient.Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults.Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.Primary colorectal non-Hodgkin's lymphoma in a retropositive patient.Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.Antiretroviral nanoparticles: an extended drug delivery modality.Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study.Guidelines for the management of diffuse large B-cell lymphoma.

P2860

Q27022706-35550EB2-4948-42D5-B574-2E653D7EFAE5 Q28081273-8D42A3F2-D973-4083-8778-A6242F73584F Q28388876-E00E7D1F-0BE2-480C-88B6-65EA87DB38D4 Q28478065-706D4DA2-0DC1-4272-901D-8F7D6A69E070 Q33598231-F3DB041C-9FE6-42CF-AA88-33B8C3D05BBA Q33710567-25DF5A33-995B-4A6F-B0A3-4920A92B4030 Q33813372-ECEAFA0E-41AA-447B-B526-8F3DC3A6F7B0 Q33856851-C8B38CDF-AEF6-48BE-A0D8-F086B5302737 Q34498993-CA0398F2-839D-48E8-A9AC-7F66688A8677 Q34661370-B95A746E-474A-4B9B-A4CF-E0BAC3A67A96 Q34796517-132C80D9-1E4A-408F-A678-AC0B1209057D Q35217255-C16BDF66-F4BA-41D5-B575-E489A89E02C4 Q35865085-6D2C0828-086B-4DA1-A71F-F58004C049B2 Q36082304-0347E787-6B76-47B1-A3DB-BCC8A8735A58 Q36102589-1D4B43C3-A01D-493E-9530-E618846B8D2B Q36166583-D1CC5E3A-F211-4DC1-8A61-441AE7E1572C Q36490052-2EF526C3-1FFF-4F3D-96FF-AF7CD536C07B Q37094777-1608F31C-CE8A-40AA-B36A-D991F5A47B55 Q37106782-01346DA8-3BA7-41BE-8108-C12295ED1012 Q37288434-E9B3CAE0-88E6-4E3B-8D84-A181EAE1C8EF Q37613180-0FB8CE2E-2651-40BA-B23D-611FB78E5FE5 Q38029093-EAC59176-9806-4080-982A-1545E304FD2C Q38183780-55FC252F-4C91-4B03-8C8F-B2BC5B838D66 Q38592494-D475E646-B323-438D-BF38-18EF755B6A96 Q38615024-EAEEE9AD-CBBF-4BAA-AA37-1247FEE2CF8C Q39339439-39840224-E5CC-4AAA-B083-F79BD90243BE Q39455597-F82738A1-4486-4301-A637-BF3F95C1D110 Q39550582-2AEC157D-3AA9-43E5-AD32-E3C1CA14DA5D Q40250347-99E8ACAD-A7A9-40F8-B970-B244DA6062FE Q40327792-B1B31257-6979-44C0-AA6B-0C32A14D243A Q40777521-E0366036-61C4-4494-842E-42CC253FD8C4 Q41244407-798D9994-7089-470E-AC12-CC217587CE8D Q41677169-9769E694-F8DC-4473-90A5-62FE382BC256 Q41899350-66AAF072-25C8-4A38-B614-A800DAC583BA Q44314941-2801C4D2-8753-4593-BDAF-D7813DAF1500 Q46035288-1CD71469-1143-45A9-8002-FDA9EC643838 Q47266595-33D791A4-7C2C-421C-AC64-23F04DB9F616 Q51732134-9FD779C5-870A-475D-A751-3233AC7D10E2 Q54708579-9DA1716F-BF40-4367-9381-F7E318DE0A93

P2860

Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.

http://www.wikidata.org/entity/Q34806379

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Immunologic and virologic pred ...... ve antiretroviral therapy era.

@ast

Immunologic and virologic pred ...... ve antiretroviral therapy era.

@en

Immunologic and virologic pred ...... ve antiretroviral therapy era.

@nl

type

label

Immunologic and virologic pred ...... ve antiretroviral therapy era.

@ast

Immunologic and virologic pred ...... ve antiretroviral therapy era.

@en

Immunologic and virologic pred ...... ve antiretroviral therapy era.

@nl

prefLabel

Immunologic and virologic pred ...... ve antiretroviral therapy era.

@ast

Immunologic and virologic pred ...... ve antiretroviral therapy era.

@en

Immunologic and virologic pred ...... ve antiretroviral therapy era.

@nl

P1433

Q34806379-AF8F72CA-335F-41F7-8B01-F7703D6BDCC5

P1476

Q34806379-8859210D-EDE4-4ED6-B53D-F2478A48E254

P2093

Q34806379-1DBC84F4-22D9-4EBE-811D-6AC337235EC8

Q34806379-5A1FD51C-2D69-4C4D-8E95-7A5D41118CA3

Q34806379-DE42B845-64AC-491A-9830-D2378303D6AB

P2860

Q34806379-07D5ABCA-693E-4224-A885-D08E394E5E98

Q34806379-0DD90A65-F100-4FBA-A1AC-AF1D0A02214D

Q34806379-11AAEE13-4E82-47AE-A02B-100456B96561

Q34806379-16AE03F2-FDDB-4070-BEE5-03C6C19AFE93

Q34806379-289928A2-B6EE-4DF7-8AE2-DA26704AE5F4

Q34806379-81540801-BDCB-4CAA-896D-62890D0FADC5

Q34806379-8E5ECF25-4E30-479D-B108-8502D273E3BC

Q34806379-947CE74C-EC0B-4546-BE7B-4BB32C1DC007

Q34806379-981F31CD-1E08-4226-BABF-8B8542E482D8

Q34806379-9D759D00-77DC-451B-A869-F84F4BF90061

P304

Q34806379-BE8C7388-E2C1-4ED6-B798-7D01A5F853E3

P31

Q34806379-BF9EE9F9-BB04-4956-8E8B-58F1D90FC4AA

P356

Q34806379-EDD7C168-0BB9-4AB7-B571-2F5809FC22C5

P407

Q34806379-09373E24-9173-4418-8752-198856C79CF5

P433

Q34806379-D2C97265-A5C8-45D6-9D42-575BA2DE25FB

P478

Q34806379-D6A6C66D-761D-4A8E-9546-81C5F27277DB

P50

Q34806379-5DCE0483-FF3C-4F5E-B8BF-36124C62636E

P577

Q34806379-9EAE1D88-F52E-408C-82EF-0BDC50C2CA3C

P5875

Q34806379-09BB869E-1F1D-4EED-A199-03714AF53CE7

P698

Q34806379-66CACDFC-AC77-46ED-99AE-8D083D8EE5A7

P921

Q34806379-77F0AD63-CA60-4DA8-8DD8-28906CA3B62A

Q34806379-C7BE7060-0E9B-4312-ABD3-2E5581240CFD

P932

Q34806379-9478FBF2-7DD1-42C6-84D3-ED356A4E270A

P356

01.QAI.0000371677.48743.8D

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Immunologic and virologic pred ...... ve antiretroviral therapy era.

@en

P2093

Eric A Engels

http://www.w3.org/2001/XMLSchema#string

Richard D Moore

http://www.w3.org/2001/XMLSchema#string

Ruth M Pfeiffer

http://www.w3.org/2001/XMLSchema#string

P2860

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms.

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

Trends in cancer risk among people with AIDS in the United States 1980-2002.

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.

B lymphocyte dysfunctions in HIV infection.

Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-associated molecular lesions.

P304

78-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.QAI.0000371677.48743.8D

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43343108

http://www.w3.org/2001/XMLSchema#string

P698

20418723

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3078556

http://www.w3.org/2001/XMLSchema#string